{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:12:23Z","timestamp":1776831143433,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Proliferative retinopathy is an uncommon feature of Vogt Koyanagi Harada (VKH) disease which might indicate poor uveitis control in these patients. We aim to describe the clinical features and outcome of management of proliferative retinopathy in 2 patients with VKH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Presentation<\/jats:title><jats:p>19 and 33\u00a0years old females with VKH presented with unilateral proliferative retinopathy. Both patients had neovascularization of the optic disc (NVDs) and one patient had neovascularizations elsewhere (NVEs) and preretinal hemorrhage. Both patients had exudative retinal detachments (ERD). Systemic steroids and immunomodulatory agents were successfully used to control inflammation and achieve regression. One patient developed fibrous tissue formation at the disc area as well as an epiretinal membrane formation, for which she had pars plana vitrectomy with membrane peeling. Both patients had controlled inflammation with stable vision.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Proliferative retinopathy can present variably in VKH patients and indicates persistent inflammation which is incompletely controlled. Proper uveitis control is sufficient to achieve regression of retinal neovascularization.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12886-020-01736-y","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T12:03:23Z","timestamp":1606824203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Proliferative retinopathy as a\u00a0feature of Vogt Koyanagi Harada Disease: a report of two cases"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6350-7464","authenticated-orcid":false,"given":"Moustafa S.","family":"Magliyah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmajeed S.","family":"Al-Fakhri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan A.","family":"Al-Dhibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"issue":"4","key":"1736_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0039-6257(05)80105-5","volume":"39","author":"RS Moorthy","year":"1995","unstructured":"Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39(4):265\u201392. https:\/\/doi.org\/10.1016\/s0039-6257(05)80105-5.","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"1736_CR2","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1001\/archopht.1996.01100140384003","volume":"114","author":"S Nakamura","year":"1996","unstructured":"Nakamura S, Nakazawa M, Yoshioka M, et al. Melanin-laden macrophages in cerebrospinal fluid in Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol. 1996;114(10):1184\u20138. https:\/\/doi.org\/10.1001\/archopht.1996.01100140384003.","journal-title":"Arch Ophthalmol"},{"key":"1736_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/00016489.2013.868604","volume":"134","author":"Y Noguchi","year":"2014","unstructured":"Noguchi Y, Nishio A, Takase H, et al. Audiovestibular findings in patients with Vogt\u2013Koyanagi\u2013Harada disease. Acta Otolaryngol. 2014;134:339\u201344. https:\/\/doi.org\/10.3109\/00016489.2013.868604.","journal-title":"Acta Otolaryngol"},{"issue":"2\u20133","key":"1736_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10792-006-9017-6","volume":"27","author":"S Sukavatcharin","year":"2007","unstructured":"Sukavatcharin S, Tsai JH, Rao NA. Vogt-Koyanagi-Harada disease in Hispanic patients. Int Ophthalmol. 2007;27(2\u20133):143\u20138. https:\/\/doi.org\/10.1007\/s10792-006-9017-6.","journal-title":"Int Ophthalmol"},{"issue":"5","key":"1736_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3109\/09273948.2015.1025984","volume":"24","author":"JF Arevalo","year":"2016","unstructured":"Arevalo JF, Lasave AF, Gupta V, et al. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center. Ocul Immunol Inflamm. 2016;24(5):521\u20139. https:\/\/doi.org\/10.3109\/09273948.2015.1025984.","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"1736_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/ICU.0000000000000206","volume":"26","author":"BM Burkholder","year":"2015","unstructured":"Burkholder BM. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol. 2015;26(6):506\u201311. https:\/\/doi.org\/10.1097\/ICU.0000000000000206.","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"1736_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/archopht.1990.01070090020013","volume":"108","author":"KW To","year":"1990","unstructured":"To KW, Nadel AJ, Brockhurst RJ. Optic Disc Neovascularization in Association With Vogt-Koyanagi-Harada Syndrome. Arch Ophthalmol. 1990;108(7):918\u20139. https:\/\/doi.org\/10.1001\/archopht.1990.01070090020013.","journal-title":"Arch Ophthalmol"},{"key":"1736_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/archopht.1974.03900060017005","volume":"91","author":"PJ Kanter","year":"1974","unstructured":"Kanter PJ, Goldberg MF. Bilateral uveitis with exudative retinal detachment: angiographic appearance. Arch Ophthalmol. 1974;91:13\u20139. https:\/\/doi.org\/10.1001\/archopht.1974.03900060017005.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"1736_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/s0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647\u201352. https:\/\/doi.org\/10.1016\/s0002-9394(01)00925-4.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1736_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ophtha.2018.08.001","volume":"126","author":"JK Sun","year":"2019","unstructured":"Sun JK, Glassman AR, Beaulieu WT, Stockdale CR, Bressler NM, Flaxel C, Gross JG, Shami M, Jampol LM. Diabetic Retinopathy Clinical Research Network. Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy. Ophthalmology. 2019;126(1):87\u201395. https:\/\/doi.org\/10.1016\/j.ophtha.2018.08.001.","journal-title":"Ophthalmology"},{"key":"1736_CR11","doi-asserted-by":"publisher","unstructured":"Suzuki H, Isaka M, Suzuki S. Type 1 diabetes mellitus associated with Graves\u2019 disease and Vogt-Koyanagi-Harada syndrome. Intern Med. 2008;47(13):1241\u20134. https:\/\/doi.org\/10.2169\/internalmedicine.47.0715.","DOI":"10.2169\/internalmedicine.47.0715"},{"issue":"6","key":"1736_CR12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3928\/1542-8877-20001101-10","volume":"31","author":"Y Maruyama","year":"2000","unstructured":"Maruyama Y, Hayashi H, Takahashi K, Iino K, Kora Y. A case of insulin dependent diabetes mellitus following systemic treatment for Vogt-Koyanagi-Harada syndrome. Ophthalmic Surg Lasers. 2000;31(6):487\u201390.","journal-title":"Ophthalmic Surg Lasers"},{"issue":"766","key":"1736_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/pgmj.65.766.587","volume":"65","author":"N Jaggarao","year":"1989","unstructured":"Jaggarao N, Voth D, Jacobsen J. The Vogt-Koyanagi-Harada syndrome: association with hypothyroidism and diabetes mellitus. Postgrad Med J. 1989;65(766):587\u20138. https:\/\/doi.org\/10.1136\/pgmj.65.766.587.","journal-title":"Postgrad Med J"},{"issue":"1","key":"1736_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/112067210601600130","volume":"16","author":"AI Al Hemidan","year":"2006","unstructured":"Al Hemidan AI, Tabbara KF, Althomali T. Vogt-Koyanagi-Harada associated with diabetes mellitus and celiac disease in a 3-year-old girl. Eur J Ophthalmol. 2006;16(1):173\u20137. https:\/\/doi.org\/10.1177\/112067210601600130.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"1736_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/09273948.2011.630548","volume":"20","author":"E Ojaimi","year":"2012","unstructured":"Ojaimi E, Levy J, Stawell R, Van Heerden A, Godfrey T, Zamir E. Vogt-Koyanagi-Harada disease, diabetes mellitus, and psoriasis in a child. Ocul Immunol Inflamm. 2012;20(1):56\u20138. https:\/\/doi.org\/10.3109\/09273948.2011.630548.","journal-title":"Ocul Immunol Inflamm"},{"key":"1736_CR16","doi-asserted-by":"publisher","first-page":"6887","DOI":"10.1038\/srep06887","volume":"4","author":"T Shi","year":"2014","unstructured":"Shi T, Lv W, Zhang L, et al. Association of HLA-DR4\/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: A Systematic Review and Meta-analysis. Sci Rep. 2014;4:6887. https:\/\/doi.org\/10.1038\/srep06887.","journal-title":"Sci Rep"},{"issue":"3","key":"1736_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ophtha.2015.10.056","volume":"123","author":"AK Patel","year":"2016","unstructured":"Patel AK, Newcomb CW, Liesegang TL, et al. Risk of Retinal Neovascularization in Cases of Uveitis. Ophthalmology. 2016;123(3):646\u201354. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.056.","journal-title":"Ophthalmology"},{"issue":"1","key":"1736_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.biocel.2009.10.006","volume":"42","author":"P Sapieha","year":"2010","unstructured":"Sapieha P, Hamel D, Shao Z, et al. Proliferative retinopathies: angiogenesis that blinds. Int J Biochem Cell Biol. 2010;42(1):5\u201312. https:\/\/doi.org\/10.1016\/j.biocel.2009.10.006.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"1736_CR19","doi-asserted-by":"publisher","first-page":"e780","DOI":"10.1111\/aos.14039","volume":"97","author":"AM Abu El-Asrar","year":"2019","unstructured":"Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, Gikandi PW, Opdenakker G, Van Damme J, Struyf S. Expression of interleukin (IL)-10 family cytokines in aqueous humour of patients with specific endogenous uveitic entities: elevated levels of IL-19 in human leucocyte antigen-B27-associated uveitis. Acta Ophthalmol. 2019;97(5):e780\u20134. https:\/\/doi.org\/10.1111\/aos.14039.","journal-title":"Acta Ophthalmol"},{"key":"1736_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41433-019-0652-3","volume":"34","author":"M Zhao","year":"2020","unstructured":"Zhao M, Sun Y, Jiang Y. Anti-VEGF therapy is not a magic bullet for diabetic retinopathy. Eye. 2020;34:609\u201310. https:\/\/doi.org\/10.1038\/s41433-019-0652-3.","journal-title":"Eye"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01736-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-020-01736-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01736-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:03:11Z","timestamp":1669917791000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01736-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01736-y","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"10 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent were obtained from and Institutional Review Board at King Khaled Eye Specialist Hospital. All patients involved were consented to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from both patients for publication of this Case report study with all accompanying images. Copies of written consents are available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.Each of the authors involved in this study has no proprietary interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"470"}}